Portfolio company
Proscia
United States · £18.2m raised
Raised
£18.2m
Latest stage
Series B
Rounds recorded
1
Backed by
2 investors
Sectors
About
This company develops a digital pathology platform and artificial intelligence software for laboratories, hospitals and biopharmaceutical organisations.
SourceFunding history · 1
Similar companies
PathAI
This company provides artificial intelligence software for pathology to support biopharmaceutical firms and clinical laboratories with drug development and diagnostic analysis.
Deciphex
This company develops AI-powered digital pathology software and diagnostic platforms for pharmaceutical organisations, contract research laboratories and clinical healthcare providers.
AI Pathology
This company develops artificial intelligence software for cancer diagnosis and digital pathology image analysis to support pathologists and laboratories.
Tribun Health
This company develops digital pathology software for diagnostic laboratories and pharmaceutical companies to manage and analyse cellular images using artificial intelligence.
Viseur AI
This company develops an artificial intelligence platform for medical imaging and digital pathology workflows to assist healthcare professionals in hospitals and diagnostic laboratories.
Panakeia
The company develops artificial intelligence software to provide rapid molecular cancer biomarker analysis from tissue images for hospitals and pharmaceutical research organisations.
Mindpeak
This company develops artificial intelligence software for automated tissue analysis and cancer diagnostics for pathology laboratories and pharmaceutical firms.
Medmain
This company develops an artificial intelligence platform for digital pathology to assist medical practitioners with image diagnosis and specimen management.
